HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK Exits Consumer Health With Haleon Launch

Executive Summary

The global market leader in consumer health is now Haleon following its separation from GSK after more than two years of planning.

You may also be interested in...



Why Spin Out? IQVIA Consumer Health On The Standalone Trend In OTC

Greater flexibility, a higher tolerance to risk, longer investment time-lines and access to a wider pool of next generation talent are some of the benefits to consumer health businesses when separating from their pharma parents, according to IQVIA Consumer Health. 

US Short Of Top 10 Countries In Overall Self-Care Access, Haleon ‘Health Inclusivity’ Study Shows

UK consumer health firm-funded Economist Impact study found the US ranks 11th among the 40 researched countries in health inclusivity, which the study defines as increasing opportunities for as many people as possible to enjoy better everyday health.

Haleon Invests In Healthcare Professionals With Centre for Human Sciences Launch

Haleon has established its Centre for Human Sciences to foster collaboration between academics in human behavior and frontline healthcare professionals. The consumer health giant hopes the initiative will help solve some of the most pressing challenges facing healthcare professionals.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel